Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Econazole Nitrate Cream in Tinea Pedis
NCT03129321Phase 3Completed
- Sponsor
- Mylan
- Start
- Mar 2016
- Primary completion
- Nov 2016
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of econazole in tinea pedis (3 arms), sponsored by Mylan. Primary endpoint: Proportion of Patients Considered a Therapeutic Cure at Day 42. Started Mar 2016; status: completed.
02
Drugs
econazole
03
Conditions
tinea pedis
Beyond the preview
Go deeper on NCT03129321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03129321.